Insmed

NASDAQ: INSM · Real-Time Price · USD
126.78
-0.97 (-0.76%)
At close: Aug 15, 2025, 12:14 PM

Insmed Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
107.42M 92.82M 104.44M 93.42M 90.34M 75.5M 83.69M 79.07M 77.23M 65.21M 59.3M 67.73M 65.22M 53.11M 56.12M 46.76M 45.37M 40.21M
Cost of Revenue
29.34M 21.28M 26.15M 21.17M 22.23M 18.72M 18.44M 16.71M 16.59M 13.83M 13.07M 13.47M 16.39M 12.19M 13.29M 10.18M 10.84M 9.84M
Gross Profit
78.08M 71.55M 78.29M 72.25M 68.11M 56.78M 65.25M 62.37M 60.63M 51.38M 46.23M 54.26M 48.83M 40.92M 42.84M 36.57M 34.53M 30.37M
Operating Income
-253.88M -248.14M -230.41M -213.43M -185.2M -157.41M -178.27M -147.67M -235.53M -157.66M -153.28M -127.7M -88.32M -101.45M -99.08M -103.62M -88.57M -83.83M
Interest Income
13.22M n/a n/a -720K 710K 754K 9.85M 666K 354K 73K 8.32M 1.79M n/a 137K n/a n/a 34K 33K
Pretax Income
-320.44M -255.67M -234.28M -219.51M -299.77M -156.5M -185.06M -158.39M -244.28M -159.28M -160M -130.77M -95.14M -94.24M -113.02M -115.29M -116.7M -91.4M
Net Income
-321.69M -256.58M -235.55M -220.52M -300.61M -157.09M -186.06M -158.93M -244.81M -159.76M -160.12M -131.15M -95.64M -94.62M -112.98M -112.71M -117.32M -91.64M
Selling & General & Admin
154.76M 147.54M 142.51M 118.93M 106.57M 93.1M 89.53M 90.63M 84.43M 79.91M 73.48M 80.82M 47.35M 56.75M 65.27M 60.28M 57.18M 51.55M
Research & Development
177.19M 152.58M 179.73M 150.81M 146.75M 121.08M 137.03M 109.15M 196.97M 127.86M 124.76M 99.87M 88.53M 84.36M 76.35M 70.35M 64.66M 61.39M
Other Expenses
n/a 19.56M n/a 15.95M -269K -1.1M 2.17M 285K -488K 1.26M 1.26M 1.26M 1.26M 1.26M n/a n/a -159K -43K
Operating Expenses
331.95M 319.69M 322.24M 285.68M 253.32M 214.19M 227.82M 201.04M 282.66M 209.04M 199.51M 181.96M 137.14M 142.37M 142.88M 131.89M 123.09M 114.2M
Interest Expense
21.25M 21.57M 21.55M 20.33M 20.18M 19.95M 20.78M 19.11M 18.97M 20M 16.45M 3.35M 2.54M 3.29M 11.35M 11.24M 10.32M 7.56M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.8M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
361.29M 340.96M 348.39M 306.85M 275.54M 232.91M 246.26M 217.74M 299.26M 222.87M 212.57M 195.43M 153.54M 154.56M 156.17M 142.07M 133.93M 124.05M
Income Tax Expense
1.24M 912K 1.27M 1.01M 838K 589K 998K 544K 530K 483K 125K 372K 501K 385K -41K -2.58M 622K 239K
Shares Outstanding (Basic)
189.3M 180.86M 179.02M 173.72M 154.7M 148.46M 144.81M 142.9M 137.55M 136.35M 132.69M 120.32M 119.56M 118.28M 118.5M 117.09M 109.58M 102.97M
Shares Outstanding (Diluted)
189.3M 180.86M 179.02M 173.72M 154.7M 148.46M 144.81M 142.9M 137.55M 136.35M 132.69M 120.79M 119.6M 118.93M 118.5M 117.09M 109.58M 103.04M
EPS (Basic)
-1.7 -1.42 -1.32 -1.27 -1.94 -1.06 -1.28 -1.11 -1.78 -1.17 -1.21 -1.09 -0.8 -0.8 -0.95 -0.96 -1.07 -0.89
EPS (Diluted)
-1.7 -1.42 -1.32 -1.27 -1.94 -1.06 -1.28 -1.11 -1.78 -1.17 -1.21 -1.09 -0.8 -0.8 -0.95 -0.96 -1.07 -0.89
EBITDA
-295.45M -232.78M -209.99M -196.56M -275.81M -132.61M -161.54M -136.45M -219.99M -133.01M -139.46M -126.13M -90.39M -86.03M -96.65M -98.61M -98.12M -80.54M
EBIT
-299.2M -235.92M -212.73M -199.18M -279.59M -136.56M -165.24M -139.28M -225.31M -140.93M -147.54M -128.24M -91.79M -91.77M -102.21M -104.05M -106.84M -84.19M
Depreciation & Amortization
3.75M 3.15M 2.74M 2.72M 2.7M 2.85M 2.74M 3.88M 6.12M 6.26M 4.1M 3.79M 9.62M 4.92M 5.02M 5.44M 8.26M 8.86M